BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed ANRO catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:f9de32c31085685d1888@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:ANRO P2 readout (est.): Study of ALTO-300 in MDD
DESCRIPTION:Study of ALTO-300 in MDD\nNCT05922878 | PHASE2 | RECRUITING | s
 ponsor: Alto Neuroscience\nPrimary completion date (ESTIMATED)\; top-line 
 results usually follow later.\nDate precision: month (shown on the first d
 ay)\nTicker ANRO (confidence 0.9)\nSource: https://clinicaltrials.gov/stud
 y/NCT05922878\nScheduling/reference data from public records\; dates can m
 ove. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05922878
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
